Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36902316 | PubTator, text mining | PubMed |
| Macrophage Biology in Human Granulomatous Skin Inflammation. | Int J Mol Sci | 2023 | 36902053 | PubTator, text mining | PubMed |
| Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations. | Cancer Cell Int | 2023 | 36899388 | PubTator, text mining | PubMed |
| A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 36895935 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity. | Front Oncol | 2023 | 36895470 | PubTator, text mining | PubMed |
| COVID-19-induced neurological symptoms: focus on the role of metal ions. | Inflammopharmacology | 2023 | 36892679 | PubTator, text mining | PubMed |
| Identification of copper death-associated molecular clusters and immunological profiles in rheumatoid arthritis. | Front Immunol | 2023 | 36891318 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. | Front Genet | 2023 | 36891150 | PubTator, text mining | PubMed |
| Cuproptosis: mechanisms and links with cancers. | Mol Cancer | 2023 | 36882769 | PubTator, text mining | PubMed |
| Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 36881404 | PubTator, text mining | PubMed |
| Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. | Front Pharmacol | 2023 | 36874011 | PubTator, text mining | PubMed |
| Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics. | Front Genet | 2023 | 36873929 | PubTator, text mining | PubMed |
| Prognostic implication of cuproptosis related genes associates with immunity in Ewing's sarcoma. | Transl Oncol | 2023 | 36871208 | PubTator, text mining | PubMed |
| Chalcone-3 Inhibits the Proliferation of Human Breast Cancer MDA-MB-231 Cell Line. | Asian Pac J Cancer Prev | 2023 | 36853320 | PubTator, text mining | PubMed |
| FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. | Proc Natl Acad Sci U S A | 2023 | 36848556 | PubTator, text mining | PubMed |
| Non-Negligible Role of Trace Elements in Influenza Virus Infection. | Metabolites | 2023 | 36837803 | PubTator, text mining | PubMed |
| Abnormal Eu3+ → Eu2+ Reduction in Ca9-xMnxEu(PO4)7 Phosphors: Structure and Luminescent Properties. | Materials (Basel) | 2023 | 36837012 | PubTator, text mining | PubMed |
| Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines. | Int J Mol Sci | 2023 | 36834962 | PubTator, text mining | PubMed |
| Role of PI3K-AKT Pathway in Ultraviolet Ray and Hydrogen Peroxide-Induced Oxidative Damage and Its Repair by Grain Ferments. | Foods | 2023 | 36832881 | PubTator, text mining | PubMed |
| Prognostic Significance of Amino Acid Metabolism-Related Genes in Prostate Cancer Retrieved by Machine Learning. | Cancers (Basel) | 2023 | 36831650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=27